(Q36262595)
Statements
Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2) (English)
Gunnar Mellgren
Olivera Bozickovic
Jan-Inge Bjune
9 November 2015
9 November 2015
1 reference
1 reference
1 reference